Cleveland Clinic researchers tracked nearly 8,000 patients in Ohio and Florida who discontinued GLP-1 medications and found ...
Millions of Americans have increasingly turned to GLP-1 medications to lose weight and improve their health. These drugs have ...
The popular GLP-1 weight-loss drug will be available via a subscription program designed to lower costs for self-pay patients ...
A Mayo Clinic study suggests postmenopausal women lost 35% more weight combining hormone therapy with tirzepatide, though ...
But while Ozempic is arguably the most recognizable drug in its class, it isn’t the only medication approved for weight ...
The FDA has approved a higher dose version of the GLP-1 drug Wegovy, which could lead to greater weight loss. The new dose is ...
The FDA has approved a higher 7.2 mg dose of Novo Nordisk’s Wegovy (Wegovy HD) for chronic weight management in adults with ...
We preselected all newsletters you had before unsubscribing.
GLP-1 drugs like tirzepatide and semaglutide offer powerful weight-loss effects but come with unanswered questions about long-term safety, side effects, and global accessibility. Researchers stress ...
We’ve all been there — feeling super inspired about a new weight loss meal plan or workout routine. You’re crushing it day after day. Then one morning, you wake up to find the wind’s gone out of your ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results